Département de Biochimie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4.
Mol Cell Endocrinol. 2013 May 22;371(1-2):20-5. doi: 10.1016/j.mce.2013.01.004. Epub 2013 Jan 19.
We present herein a review of our recent results on the characterization of the binding sites of STARD1, STARD5 and STARD6 using NMR and other biophysical techniques. Whereas STARD1 and STARD6 bind cholesterol, no cholesterol binding could be detected for STARD5. However, titration of STARD5 with cholic acid and chenodeoxycholic acid led to specific binding. Using perturbation of the (1)H-(15)N-HSQC spectra and the sequence specific NMR assignments, we identified the amino acids in contact with those ligands. The most perturbed residues in presence of ligands are lining the internal cavity of the protein. Interestingly, these residues are not conserved in STARD1 and STARD6 and could therefore be key structural determinants of the specificity of START domains toward their ligands. We highlight three tissues expressing STARD5 that are affected by bile acids.
我们在此回顾了我们最近使用 NMR 和其他生物物理技术研究 STARD1、STARD5 和 STARD6 结合位点的结果。虽然 STARD1 和 STARD6 结合胆固醇,但未检测到 STARD5 与胆固醇结合。然而,用胆酸和鹅去氧胆酸滴定 STARD5 导致特异性结合。通过(1)H-(15)N-HSQC 光谱的干扰和序列特异性 NMR 分配,我们确定了与那些配体接触的氨基酸。在存在配体的情况下,受干扰最大的残基位于蛋白质的内部腔中。有趣的是,这些残基在 STARD1 和 STARD6 中不保守,因此可能是 START 结构域与其配体特异性的关键结构决定因素。我们强调了三种表达 STARD5 的组织,这些组织受胆汁酸的影响。